MedWand®'s Latest Regulatory Green Light Enables Use of the Sensor Based Medical Device for Comprehensive Patient Assessment InternationallyThis Approval Allows MedWand to Enhance Efficiency, Convenience, and Access to Care in Thailand
By: MedWand Solutions "The regulatory clearance in Thailand reflects our dedication to making comprehensive remote healthcare services accessible worldwide," shared MedWand Senior Director of International Business Development, Stuart English. "We are thrilled to bring MedWand to Thailand, addressing healthcare needs and creating new opportunities for collaboration with international partners." MedWand is the ultimate healthcare solution, seamlessly integrating traditional tools and Bluetooth connectivity for vitals capture and remote patient evaluations to enhance efficiency, convenience, and access to care. Following its FDA clearance and product launch in the United States in 2022, MedWand has gained significant traction with major US health systems, telehealth companies, large private practices, and employers. "Following thorough research, we have identified the MedWand multi-sensor vitals capture device, together with the VirtualCare telemedicine platform, as the pivotal components essential for revolutionizing telemedicine services. This combination is poised to facilitate advanced clinical care accessible to patients regardless of their location, eliminating the necessity for hospital visits," commented Dr. Supornchai Kongpatanakul, President of Kitmeechai Trading Co., Ltd. The device's versatility and ease of use make it a valuable asset for both healthcare professionals and patients. Transforming the traditional understanding of telehealth, MedWand combines multiple vitals sensors into one, handheld, lightweight device. Data collected can include core temperature, blood oxygen saturation, and pulse rate, heart, lung and abdominal auscultations, electrocardiogram* For more information on MedWand visit www.medwand.com. To schedule a private demonstration or to request a formal quotation please contact MedWand at https://www.medwandhealth.com/ *Electrocardiogram feature is currently awaiting US FDA 510(k) clearance. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|